Type 2 inflammation accelerates CD4⁺ T-cell senescence in asthma

Area of Science:

• Immunology
• Respiratory Medicine
• Cellular Biology

Background:

• Asthma is a chronic inflammatory airway disease.
• T-cell senescence is associated with immune dysfunction and inflammation.
• The role of T-cell senescence in asthma is currently unexplored.

Purpose of the Study:

• To investigate the relationship between asthma and T-cell senescence.
• To determine the impact of T-cell senescence on asthma pathology.
• To explore potential therapeutic strategies targeting T-cell senescence in asthma.

Main Methods:

• Quantified senescent T cells (Tsens) in asthma patients and healthy controls.
• Utilized a house dust mite (HDM)-induced mouse model of asthma.
• Administered therapeutic interventions including IL-4 antibodies and dexamethasone.
• Performed adoptive transfer of CD4+ Tsens in a mouse model.

Main Results:

• Asthma patients exhibited significantly higher percentages of CD4+ Tsen compared to controls.
• CD4+ Tsen levels correlated positively with asthma severity markers (FeNO, eosinophils, Th2 cells).
• HDM-induced asthma model showed elevated CD4+ Tsen in lungs; IL-4 neutralization reduced CD4+ Tsen and p38 MAPK activation.
• Adoptive transfer of CD4+ Tsens exacerbated type 2 inflammation in HDM-treated mice.

Conclusions:

• CD4+ T-cell senescence is significantly increased in asthma patients.
• Type 2 inflammation appears to drive CD4+ T-cell senescence in asthma.
• CD4+ T-cell senescence may exacerbate type 2 inflammation in asthma, suggesting it as a therapeutic target.